CAMBRIDGE, Mass., March 02, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial stage developer
of innovative RNA-targeted therapeutics, today announced that it is scheduled to present at the Cowen and Company 37th Annual
Health Care Conference in Boston, MA on Wednesday, March 8 at 8:00 a.m. ET. Edward Kaye, Sarepta's
chief executive officer, will be the presenter at the fireside chat.
The presentation will be webcast live on the investor relations section of the Sarepta Therapeutics website
at www.sarepta.com and will be archived under the events and presentations section following
the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure
adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of unique
RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing
the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates. For more information,
please visit us at www.sarepta.com.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our web site
at www.sarepta.com. We encourage investors and potential investors to consult our website regularly
for important information about us.
Sarepta Therapeutics, Inc. Media and Investors: Ian Estepan, 617-274-4052 iestepan@sarepta.com or W2O Group Brian Reid, 212-257-6725 breid@w2ogroup.com
